Long-term Study of FK949E in Elderly Bipolar Disorder Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 29, 2012

Primary Completion Date

June 29, 2016

Study Completion Date

June 29, 2016

Conditions
Bipolar DisorderElderly
Interventions
DRUG

FK949E

Oral tablet

Trial Locations (32)

Unknown

Site JP00024, Chiba

Site JP00023, Fukuoka

Site JP00025, Fukuoka

Site JP00015, Fukushima

Site JP00029, Fukushima

Site JP00001, Hokkaido

Site JP00002, Hokkaido

Site JP00003, Hokkaido

Site JP00004, Hokkaido

Site JP00005, Hokkaido

Site JP00006, Hokkaido

Site JP00007, Hokkaido

Site JP00008, Hokkaido

Site JP00009, Hokkaido

Site JP00010, Hokkaido

Site JP00011, Hokkaido

Site JP00012, Hokkaido

Site JP00013, Hokkaido

Site JP00028, Hyōgo

Site JP00031, Ibaraki

Site JP00017, Kanagawa

Site JP00032, Kanagawa

Site JP00019, Kumamoto

Site JP00018, Kyoto

Site JP00014, Osaka

Site JP00016, Tokyo

Site JP00020, Tokyo

Site JP00021, Tokyo

Site JP00022, Tokyo

Site JP00026, Tokyo

Site JP00027, Tokyo

Site JP00030, Tottori

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY